🌟 Did you know? 🌟 72% of rare diseases are genetic in origin, affecting millions of people worldwide. These conditions often start in childhood and can significantly impact the lives of patients and their families. Understanding the genetic basis of these diseases is crucial for developing effective treatments and providing better care. Let's continue to raise awareness and support research efforts to improve the lives of those affected by rare diseases. 💙 #RareDiseaseDay #Genetics #Awareness
Kedrion Biopharma - USA
Pharmaceutical Manufacturing
Fort Lee, New Jersey 5,646 followers
Keep life flowing.
About us
Kedrion Biopharma launched US operations in 2011, but the company’s international roots stretch back several decades in the production of blood and plasma-derived products. It places a high value not only on the welfare of those who benefit from its products but also on the people and communities it serves. For more information please visit https://www.kedrion.us/about-us/.
- Website
-
https://www.kedrion.us/
External link for Kedrion Biopharma - USA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Fort Lee, New Jersey
- Type
- Privately Held
Locations
-
Primary
Get directions
400 Kelby St
Fort Lee, New Jersey 07024, US
Employees at Kedrion Biopharma - USA
Updates
-
🌍 Did you know there are over 6,000 known rare diseases? 🌍 Rare diseases affect millions of people worldwide, yet each condition impacts a relatively small number of individuals. This makes research, diagnosis, and treatment particularly challenging. 💡 Awareness and advocacy are crucial to support those living with rare diseases and to drive advancements in medical research. Together, we can make a difference by spreading knowledge and fostering a community of support. #RareDiseasesDay #Awareness #Advocacy
-
-
🌍 3️⃣0️⃣0️⃣ MILLION people worldwide live with a rare disease. Today, we recognize the strength and resilience of those affected by rare diseases. Each individual story is a testament to the power of hope, innovation, and community support. At Kedrion, delivering plasma derived therapies that address the needs of these patients is our passion. Together, we can make a difference and bring much-needed attention to the challenges faced by the rare disease community. Let's continue to raise awareness and work towards a future where everyone has access to the care they deserve. 💚💙💜 #RareDiseaseDay #PatientCare
-
-
🌍 3️⃣0️⃣0️⃣ MILLION people worldwide live with a rare disease. Today, we recognize the strength and resilience of those affected by rare diseases. Each individual story is a testament to the power of hope, innovation, and community support. At Kedrion, delivering plasma derived therapies that address the needs of these patients is our passion. Together, we can make a difference and bring much-needed attention to the challenges faced by the rare disease community. Let's continue to raise awareness and work towards a future where everyone has access to the care they deserve. 💚💙💜 #RareDiseaseDay #PatientCare
-
-
A beautiful tribute for the hard work and dedication of our team committed to raising awareness to rare disease and the communities of patients and caregivers impacted. #RareDiseaseDay
The Affianco project was born from the desire to listen, understand, and offer concrete support to those who too often feel alone. We immediately felt close to AIP's goal because Kedrion, like this association, is made up of people who put their hearts into their work, aware that research and innovation are fundamental, but that empathy and human connection are just as important. For these reasons, we are so proud of Affianco's victory for “Best Communication Campaign – nonprofessionals” at the OMaR Award, a prize that recognizes communication on rare diseases and rare tumors. Yesterday evening in Rome, we were deeply moved and excited to collect the award together. Given the proximity to #RareDiseaseDay, today we celebrate not only this achievement but, above all, the strength of a community that never gives up. This award is for all of them. For patients, their families, volunteers, plasma donors and the healthcare professionals who support these communities so closely every day. But it is also for all those who believe in a future where no one is left behind. Ilaria Ciancaleoni Bartoli Osservatorio Malattie Rare Silvia Casati
-
-
February is Black History Month, a time to celebrate the contributions and achievements of Black Americans and an opportunity to recognize their integral role in American history. From trailblazers like Martin Luter King Jr and Rosa Parks, to modern day innovators like Victor Glover and Amanda Gorman, American history is filled with stories of resilience, courage and excellence. This month, and every month forward, let’s commit to continuing the ongoing journey towards equality for all Americans, because true progress happens when we turn AWARENESS into ACTION. #BlackHistoryMonth
-
-
Whether or not you mark this day with service, Martin Luther King Jr. Day is an important reminder of the power of unity, equality, and justice. Dr. King’s legacy transcends just one day of reflection; it’s a call to action for all of us to continue striving for a world where all people are treated with dignity and respect. As we remember his work and vision, let's ask ourselves: How can we contribute to making our workplaces, communities, and networks more inclusive? Whether through small acts of kindness, championing diversity, or standing up for what is right, each step counts. Dr. King believed that "the time is always right to do what is right." Today and every day, let’s honor his memory by embodying his values in our words and actions. #MLKDay #Equality #Justice #Inclusion #Leadership #Service
-
-
🎉 Exciting News! 🎉 We are thrilled to announce that we have received FDA approval for our manufacturing of Ryplazim in our Bolognana Facility! This milestone is a testament to our team's hard work, dedication, and commitment to innovation. Thank you to everyone who supported us on this journey. We look forward to making a positive impact on the PLGD-1 community and continuing to drive excellence in everything we do. #FDAApproval #PlasminogenDeficiency #Ryplazim #PLGD1 #TeamSuccess 👍 https://lnkd.in/ePf8n4Gn
This content isn’t available here
Access this content and more in the LinkedIn app
-
🎤 𝗩𝗼𝗶𝗰𝗲𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗣𝗜𝗗 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆: 𝗔 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗝𝗼𝗿𝗲𝘆 𝗕𝗲𝗿𝗿𝘆, 𝗜𝗺𝗺𝘂𝗻𝗲 𝗗𝗲𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝖣𝗎𝗋𝗂𝗇𝗀 𝗍𝗁𝖾 𝗋𝖾𝖼𝖾𝗇𝗍 𝗘𝗦𝗜𝗗 𝗮𝗻𝗱 𝗚𝗣𝗠 𝟮𝟬𝟮𝟰 𝖾𝗏𝖾𝗇𝗍𝗌, 𝗐𝖾 𝗁𝖺𝖽 𝗍𝗁𝖾 𝗉𝗋𝗂𝗏𝗂𝗅𝖾𝗀𝖾 𝗈𝖿 𝗆𝖾𝖾𝗍𝗂𝗇𝗀 Jorey Berry, 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗮𝗻𝗱 𝗖𝗘𝗢 𝗈𝖿 Immune Deficiency Foundation (𝖨𝖣𝖥). 𝖶𝖾 𝖾𝗇𝗀𝖺𝗀𝖾𝖽 𝗂𝗇 𝗆𝖾𝖺𝗇𝗂𝗇𝗀𝖿𝗎𝗅 𝖽𝗂𝗌𝖼𝗎𝗌𝗌𝗂𝗈𝗇𝗌 𝖺𝖻𝗈𝗎𝗍 𝗍𝗁𝖾 𝗸𝗲𝘆 𝗽𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗣𝗜𝗗 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦. 𝖳𝗁𝖾 𝖨𝖣𝖥 𝗂𝗌 𝖺 𝗇𝗈𝗇-𝗉𝗋𝗈𝖿𝗂𝗍 𝗈𝗋𝗀𝖺𝗇𝗂𝗓𝖺𝗍𝗂𝗈𝗇 𝖽𝖾𝖽𝗂𝖼𝖺𝗍𝖾𝖽 𝗍𝗈 𝗂𝗆𝗉𝗋𝗈𝗏𝗂𝗇𝗀 𝗍𝗁𝖾 𝖽𝗂𝖺𝗀𝗇𝗈𝗌𝗂𝗌, 𝗍𝗋𝖾𝖺𝗍𝗆𝖾𝗇𝗍, 𝖺𝗇𝖽 𝗊𝗎𝖺𝗅𝗂𝗍𝗒 𝗈𝖿 𝗅𝗂𝖿𝖾 𝖿𝗈𝗋 𝗂𝗇𝖽𝗂𝗏𝗂𝖽𝗎𝖺𝗅𝗌 𝗐𝗂𝗍𝗁 𝖯𝗋𝗂𝗆𝖺𝗋𝗒 𝖨𝗆𝗆𝗎𝗇𝗈𝖽𝖾𝖿𝗂𝖼𝗂𝖾𝗇𝖼𝗒 𝖽𝗂𝗌𝖾𝖺𝗌𝖾𝗌 𝗍𝗁𝗋𝗈𝗎𝗀𝗁 𝖺𝖽𝗏𝗈𝖼𝖺𝖼𝗒, 𝖾𝖽𝗎𝖼𝖺𝗍𝗂𝗈𝗇, 𝖺𝗇𝖽 𝗌𝗎𝗉𝗉𝗈𝗋𝗍. 𝖠𝗌 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗱𝘃𝗼𝗰𝗮𝗰𝘆 𝗮𝗻𝗱 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝖺𝗋𝖾 𝖼𝗋𝗎𝖼𝗂𝖺𝗅 𝗍𝗈 𝗈𝗎𝗋 𝗆𝗂𝗌𝗌𝗂𝗈𝗇 𝗍𝗈 𝗂𝗆𝗉𝗋𝗈𝗏𝖾 𝗍𝗁𝖾 𝗅𝗂ves 𝗈𝖿 𝗉𝖺𝗍𝗂𝖾𝗇𝗍𝗌 𝗐𝗈𝗋𝗅𝖽𝗐𝗂𝖽𝖾, 𝗐𝖾’𝗋𝖾 𝗉𝗋𝗈𝗎𝖽 𝗍𝗈 𝗋𝖺𝗂𝗌𝖾 𝗍𝗁𝖾 𝗏𝗈𝗂𝖼𝖾𝗌 𝗈𝖿 𝗂𝗇𝗍𝖾𝗋𝗇𝖺𝗍𝗂𝗈𝗇𝖺𝗅 𝖪𝖮𝖫𝗌 𝗂𝗇 𝗍𝗁𝖾 𝖯𝖨𝖣 𝖼𝗈𝗆𝗆𝗎𝗇𝗂𝗍𝗒. 🌟 𝖠 𝗁𝖾𝖺𝗋𝗍𝖿𝖾𝗅𝗍 T𝗁𝖺𝗇𝗄 Y𝗈𝗎 𝗍𝗈 𝖩𝗈𝗋𝖾𝗒 𝖿𝗈𝗋 𝗁𝖾𝗋 𝗏𝖺𝗅𝗎𝖺𝖻𝗅𝖾 𝗂𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝖺𝗇𝖽 𝖼𝗈𝗇𝗍𝗋𝗂𝖻𝗎𝗍𝗂𝗈𝗇𝗌. 𝖳𝗈𝗀𝖾𝗍𝗁𝖾𝗋, 𝗐𝖾 𝖼𝖺𝗇 𝗆𝖺𝗄𝖾 𝖺 𝖽𝗂𝖿𝖿𝖾𝗋𝖾𝗇𝖼𝖾 𝖿𝗈𝗋 𝗍𝗁𝖾 𝖯𝖨𝖣 𝖼𝗈𝗆𝗆𝗎𝗇𝗂𝗍𝗒! #𝖯𝖨𝖣 #𝖯𝖺𝗍𝗂𝖾𝗇𝗍𝖠𝖽𝗏𝗈𝖼𝖺𝖼𝗒 #𝖢𝗈𝗅𝗅𝖺𝖻𝗈𝗋𝖺𝗍𝗂𝗈𝗇 #𝖤𝖲𝖨𝖣𝟤𝟢𝟤𝟦 #𝖦𝖯𝖬𝟤𝟢𝟤𝟦